p16INK4a and p15INK4b gene methylations in plasma cells from monoclonal gammopathy of undetermined significance

被引:65
作者
Guillerm, G
Gyan, E
Wolowiec, D
Facon, T
Avet-Loiseau, H
Kuliczkowski, K
Bauters, F
Fenaux, P
Quesnel, B
机构
[1] CHU Lille, Serv Malad Sang, F-590371 Lille, France
[2] Inst Rech Canc Lille, INSERM, U524, Lille, France
[3] Wroclaw Med Univ, Dept Hematol, Wroclaw, Poland
[4] CHU Nantes, Hematol Lab, F-44035 Nantes 01, France
关键词
D O I
10.1182/blood.V98.1.244
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
p15(INK4b) and p16(INK4a) proteins are cell cycle regulators involved in the inhibition of G1 phase progression. High frequency of methylation of both genes has been reported in multiple myeloma (MM), but it remains to be determined how and when these alterations contribute to tumorigenesis. Monoclonal gammopathy of undetermined significance (MGUS) represents an early disease stage in a fraction of MMs. Plasma cells from 33 patients with MGUS and 33 patients with NIM were isolated and analyzed for p15(INK4b) and p16(INK4a) methylation by methylation-specific polymerase chain reaction. Selective methylation was found in 19% for p16(INK4a), 36% for p15(INK4b), and 6.5% for both genes in MGUS, and frequencies were similar in MM suggesting that methylation of these genes is an early event, not associated with transition from MGUS to NIM. p15(INK4b) and p16(INK4a) gene methylation might contribute to immortalization of plasma cells rather than malignant transformation in the natural history of MM. (C) 2001 by The American Society of Hematology.
引用
收藏
页码:244 / 246
页数:3
相关论文
共 24 条
  • [1] Avet-Loiseau H, 1999, CANCER RES, V59, P4546
  • [2] Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma
    Avet-Loiseau, H
    Li, JY
    Morineau, N
    Facon, T
    Brigaudeau, C
    Harousseau, JL
    Grosbois, B
    Bataille, R
    [J]. BLOOD, 1999, 94 (08) : 2583 - 2589
  • [3] Aberrant methylation of p16INK4a is an early event in lung cancer and a potential biomarker for early diagnosis
    Belinsky, SA
    Nikula, KJ
    Palmisano, WA
    Michels, R
    Saccomanno, G
    Gabrielson, E
    Baylin, SB
    Herman, JG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (20) : 11891 - 11896
  • [4] p15INK4B CPG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing
    Cameron, EE
    Baylin, SB
    Herman, JG
    [J]. BLOOD, 1999, 94 (07) : 2445 - 2451
  • [5] Role of transforming growth factor-β signaling in cancer
    de Caestecker, MP
    Piek, E
    Roberts, AB
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (17): : 1388 - 1402
  • [6] De novo methylation of tumor suppressor gene p16/INK4a is a frequent finding in multiple myeloma patients at diagnosis
    González, M
    Mateos, MV
    García-Sanz, R
    Balanzategui, A
    López-Pérez, R
    Chillón, MC
    González, D
    Alaejos, I
    San Miguel, JF
    [J]. LEUKEMIA, 2000, 14 (01) : 183 - 187
  • [7] Multiple myeloma: Increasing evidence for a multistep transformation process
    Hallek, M
    Bergsagel, PL
    Anderson, KC
    [J]. BLOOD, 1998, 91 (01) : 3 - 21
  • [8] Herman JG, 1996, CANCER RES, V56, P722
  • [9] Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
    Herman, JG
    Graff, JR
    Myohanen, S
    Nelkin, BD
    Baylin, SB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (18) : 9821 - 9826
  • [10] Jaffrain-Rea ML, 1999, CLIN ENDOCRINOL, V51, P317